Hemostatic Bleeding Articles & Analysis
5 news found
“His deep experience as both a practicing clinician and clinical developer in the hemostatic space will accelerate development and support clinical adoption of our products. ...
Cellphire Therapeutics, Inc., a biotechnology company developing next-generation platelet-based hemostatic therapeutics for application across multiple medical indications, announced today that the first patient has been dosed in the company’s Phase 2 dose-ranging study of Thrombosomes®, a platelet-based freeze-dried hemostatic agent, in ...
ACTISEAL® functions both as a sealant, withstanding the impact of aggressive bile and pancreatic fluids, and a hemostat, controlling mild-to-moderate bleeding. The easy-to-use, 100% synthetic device is optimized to adhere to and seal the treated tissue throughout the critical healing period following HPB surgery. ...
ByRegenity
The patch functions both as a sealant, withstanding the impact of aggressive bile and pancreatic fluids, and as a hemostat, controlling mild-to-moderate bleeding. It is being developed in close association with the surgical department of the University Medical Center Hamburg-Eppendorf (UKE), Germany, and with MercachemSyncom, a contract research organization ...
ByRegenity
The presentation will provide data and descriptions of the performance of its patented hydrogel biomaterial in a series of hemostatic applications in progressively more challenging bleeding wounds. ...